FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ute Moll

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Disorders

Genes & Molecular Sequences

Physiology

Procedures

Immunohistochemistry

Co-author Network

Publications

TOP 3
Irene Ischenko; Ute M Moll; Alice Nemajerova; Jizu Zhi; Oleksi Petrenko
Direct reprogramming by oncogenic Ras and Myc.
E M Alexandrova; Flaminia Talos; Ute M Moll
p73 is dispensable for commitment to neural stem cell fate, but is essential for neural stem cell maintenance and for blocking premature differentiation.
Evguenia M Alexandrova; Ute M Moll
Generation of p53-deficient induced pluripotent stem cells from mouse embryo fibroblasts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ute Moll (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Irene Ischenko; Ute M Moll; Alice Nemajerova; Jizu Zhi; Oleksi Petrenko
Direct reprogramming by oncogenic Ras and Myc.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(10):3937-42.
2013: E M Alexandrova; Flaminia Talos; Ute M Moll
p73 is dispensable for commitment to neural stem cell fate, but is essential for neural stem cell maintenance and for blocking premature differentiation.
Cell death and differentiation 2013;20(2):368.
2013: Evguenia M Alexandrova; Ute M Moll
Generation of p53-deficient induced pluripotent stem cells from mouse embryo fibroblasts.
Methods in molecular biology (Clifton, N.J.) 2013;962():157-64.
2013: Angelina V Vaseva; Ute M Moll
Identification of p53 in mitochondria.
Methods in molecular biology (Clifton, N.J.) 2013;962():75-84.
2012: Evguenia M Alexandrova; Ute M Moll
Role of p53 family members p73 and p63 in human hematological malignancies.
Leukemia & lymphoma 2012;53(11):2116-29.
2012: Alice Nemajerova; Oleksi Petrenko; S Y Kim; Ute M Moll
Two-factor reprogramming of somatic cells to pluripotent stem cells reveals partial functional redundancy of Sox2 and Klf4.
Cell death and differentiation 2012;19(8):1268-76.
2012: Angelina V Vaseva; Stella E Tsirka; Sonja Holzmann; Kyungmin Ji; Natasha D Marchenko; Ute M Moll
p53 opens the mitochondrial permeability transition pore to trigger necrosis.
Cell 2012;149(7):1536-48.
2012: Ramona Schulz; Lars Zender; Marina Pesic; Matthias Dobbelstein; Günter Fingerle-Rowson; Lena Holembowski; Natalia D Marchenko; Ute M Moll
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression.
The Journal of experimental medicine 2012;209(2):275-89.
2011: Dun Li; Natasha D Marchenko; Ute M Moll
SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis.
Cell death and differentiation 2011;18(12):1904-13.
2011: Dun Li; Natasha D Marchenko; Ramona Schulz; Victoria Fischer; Talia Velasco-Hernandez; Flaminia Talos; Ute M Moll
Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells.
Molecular cancer research : MCR 2011;9(5):577-88.
2011: Ulrike Beyer; Julian Moll-Rocek; Ute M Moll; Matthias Dobbelstein
Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(9):3624-9.
2011: Lena Holembowski; Ramona Schulz; Flaminia Talos; Alexander K Scheel; Sonja Wolff; Matthias Dobbelstein; Ute M Moll
While p73 is essential, p63 is completely dispensable for the development of the central nervous system.
Cell cycle (Georgetown, Tex.) 2011;10(4):680-9.
2011: A V Vaseva; A R Yallowitz; N D Marchenko; S Xu; Ute M Moll
Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors.
Cell death & disease 2011;2():e156.
2010: Flaminia Talos; A Abraham; A V Vaseva; L Holembowski; S E Tsirka; A Scheel; D Bode; M Dobbelstein; W Brück; Ute M Moll
p73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis.
Cell death and differentiation 2010;17(12):1816-29.
2010: Alice Nemajerova; Oleksi Petrenko; Lorenz Trümper; Gustavo Palacios; Ute M Moll
Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.
The Journal of clinical investigation 2010;120(6):2070-80.
2010: Natasha D Marchenko; W Hanel; Dun Li; K Becker; Nancy C Reich; Ute M Moll
Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-alpha3 binding.
Cell death and differentiation 2010;17(2):255-67.
2010: Flaminia Talos; Ute M Moll
Role of the p53 family in stabilizing the genome and preventing polyploidization.
Advances in experimental medicine and biology 2010;676():73-91.
2009: L Galluzzi; S A Aaronson; J Abrams; E S Alnemri; D W Andrews; E H Baehrecke; N G Bazan; M V Blagosklonny; K Blomgren; C Borner; Dale E Bredesen; C Brenner; M Castedo; J A Cidlowski; Aaron Ciechanover; G M Cohen; V De Laurenzi; R De Maria; Mohanish Deshmukh; Brian David Dynlacht; Wafik S El-Deiry; R A Flavell; S Fulda; C Garrido; P Golstein; M-L Gougeon; D R Green; Hinrich Gronemeyer; Gyorgy Hajn\u2264czky; J Marie Hardwick; M O Hengartner; H Ichijo; M Jäättelä; O Kepp; A Kimchi; Daniel J Klionsky; R A Knight; Sally Kornbluth; S Kumar; Beth Levine; S A Lipton; E Lugli; F Madeo; W Malomi; J-C W Marine; S J Martin; J P Medema; P Mehlen; G Melino; Ute M Moll; E Morselli; S Nagata; D W Nicholson; P Nicotera; G Nuñez; M Oren; J Penninger; S Pervaiz; M E Peter; M Piacentini; J H M Prehn; H Puthalakath; G A Rabinovich; R Rizzuto; C M P Rodrigues; David C Rubinsztein; T Rudel; LUCA SCORRANO; H-U Simon; H Steller; J Tschopp; Y Tsujimoto; P Vandenabeele; I Vitale; K H Vousden; R J Youle; J Yuan; B Zhivotovsky; G Kroemer
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes.
Cell death and differentiation 2009;16(8):1093-107.
2009: S Wolff; F Talos; Gustavo Palacios; U Beyer; Matthias Dobbelstein; Ute M Moll
The alpha/beta carboxy-terminal domains of p63 are required for skin and limb development. New insights from the Brdm2 mouse which is not a complete p63 knockout but expresses p63 gamma-like proteins.
Cell death and differentiation 2009;16(8):1108-17.
2009: Angelina V Vaseva; Natasha D Marchenko; Ute M Moll
The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells.
Cell cycle (Georgetown, Tex.) 2009;8(11):1711-9.
2009: Giovanni Blandino; Ute M Moll
p63 regulation by microRNAs.
Cell cycle (Georgetown, Tex.) 2009;8(10):1466-7.
2009: Angelina V Vaseva; Ute M Moll
The mitochondrial p53 pathway.
Biochimica et biophysica acta 2009;1787(5):414-20.
2009: Neda Slade; Ute M Moll; Branko Brdar; Arijana Zorić; Bojan Jelaković
p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.
Mutation research 2009;663(1-2):1-6.
2008: Christian J Braun; Xin Zhang; Irina Savelyeva; Sonja Wolff; Ute M Moll; Troels Schepeler; Torben F Ørntoft; Claus L Andersen; Matthias Dobbelstein
p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.
Cancer research 2008;68(24):10094-104.
2008: Wei-Xing Zong; Ute M Moll
p53 in autophagy control.
Cell cycle (Georgetown, Tex.) 2008;7(19):2947.
2008: Alice Nemajerova; Flaminia Talos; Ute M Moll; Oleksi Petrenko
Rb function is required for E1A-induced S-phase checkpoint activation.
Cell death and differentiation 2008;15(9):1440-9.
2008: Gustavo Palacios; Howard C Crawford; Angelina Vaseva; Ute M Moll
Mitochondrially targeted wild-type p53 induces apoptosis in a solid human tumor xenograft model.
Cell cycle (Georgetown, Tex.) 2008;7(16):2584-90.
2008: Sonja Wolff; susan erster; Gustavo Palacios; Ute M Moll
p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity.
Cell research 2008;18(7):733-44.
2008: Gustavo Palacios; Flaminia Talos; Alice Nemajerova; Ute M Moll; Oleksi Petrenko
E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression.
Cell cycle (Georgetown, Tex.) 2008;7(12):1776-81.
2008: Ezgi Tasdemir; M Chiara Maiuri; Lorenzo Galluzzi; Ilio Vitale; Mojgan Djavaheri-Mergny; Marcello D'Amelio; Alfredo Criollo; Eugenia Morselli; Changlian Zhu; Francis Harper; Ulf Nannmark; Chrysanthi Samara; Paolo Pinton; José Miguel Vicencio; Rosa Carnuccio; Ute M Moll; Frank Madeo; Patrizia Paterlini-Brechot; Rosario Rizzuto; Gyorgy Szabadkai; Gérard Pierron; Klas Blomgren; Nektarios Tavernarakis; Patrice Codogno; Francesco Cecconi; Guido Kroemer
Regulation of autophagy by cytoplasmic p53.
Nature cell biology 2008;10(6):676-87.
2008: Kerstin Becker; Natasha D Marchenko; Gustavo Palacios; Ute M Moll
A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model.
Cell cycle (Georgetown, Tex.) 2008;7(9):1205-13.
2008: Mirko Marabese; Sergio Marchini; Eleonora Marrazzo; Pietro Mariani; Dario Cattaneo; Roldano Fossati; Anna Compagnoni; Mauro Signorelli; Ute M Moll; Annamaria Codegoni; Massimo Broggini
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
European journal of cancer (Oxford, England : 1990) 2008;44(1):131-41.
2007: Flaminia Talos; Alice Nemajerova; Elsa R Flores; Oleksi Petrenko; Ute M Moll
p73 suppresses polyploidy and aneuploidy in the absence of functional p53.
Molecular cell 2007;27(4):647-59.
2007: Arthur P Grollman; Shinya Shibutani; Masaaki Moriya; Frederick Miller; Lin Wu; Ute M Moll; Naomi Suzuki; Andrea Fernandes; Thomas A Rosenquist; Zvonimir Medverec; Krunoslav Jakovina; Branko Brdar; Neda Slade; Robert J Turesky; Angela K Goodenough; Robert Rieger; Mato Vukelić; Bojan Jelaković
Aristolochic acid and the etiology of endemic (Balkan) nephropathy.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(29):12129-34.
2007: Natasha D Marchenko; Ute M Moll
The role of ubiquitination in the direct mitochondrial death program of p53.
Cell cycle (Georgetown, Tex.) 2007;6(14):1718-23.
2007: K Becker; Natasha D Marchenko; M Maurice; Ute M Moll
Hyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastoma.
Cell death and differentiation 2007;14(7):1350-60.
2007: Alice Nemajerova; Ute M Moll; Oleksi Petrenko; Gunter Fingerle-Rowson
Macrophage migration inhibitory factor coordinates DNA damage response with the proteasomal control of the cell cycle.
Cell cycle (Georgetown, Tex.) 2007;6(9):1030-4.
2007: Jose J Fuster; Silvia M Sanz-González; Ute M Moll; Vicente Andrés
Classic and novel roles of p53: prospects for anticancer therapy.
Trends in molecular medicine 2007;13(5):192-9.
2007: Alice Nemajerova; Patricio Mena; Gunter Fingerle-Rowson; Ute M Moll; Oleksi Petrenko
Impaired DNA damage checkpoint response in MIF-deficient mice.
The EMBO journal 2007;26(4):987-97.
2007: Natasha D Marchenko; Sonja Wolff; susan erster; Kerstin Becker; Ute M Moll
Monoubiquitylation promotes mitochondrial p53 translocation.
The EMBO journal 2007;26(4):923-34.
2006: Gustavo Palacios; Ute M Moll
Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo.
Oncogene 2006;25(45):6133-9.
2006: Kerstin Becker; Petr Pancoska; Nicole Concin; Kelly Vanden Heuvel; Neda Slade; Margaret Fischer; Eva Chalas; Ute M Moll
Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers.
International journal of oncology 2006;29(4):889-902.
2006: Ute M Moll; Natasha D Marchenko; X-K Zhang
p53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction.
Oncogene 2006;25(34):4725-43.
2006: York Tomita; Natasha D Marchenko; susan erster; Alice Nemajerova; Alexander Dehner; Christian Klein; Hongguang Pan; Horst Kessler; Petr Pancoska; Ute M Moll
WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization.
The Journal of biological chemistry 2006;281(13):8600-6.
2006: Xiaokui Yang; Michael Fraser; Ute M Moll; Ajoy Basak; Benjamin K Tsang
Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.
Cancer research 2006;66(6):3126-36.
2006: susan erster; Gustavo Palacios; T Rosenquist; C Chang; Ute M Moll
Deregulated expression of DeltaNp73alpha causes early embryonic lethality.
Cell death and differentiation 2006;13(1):170-3.
2005: Nicole Concin; Gerda Hofstetter; Astrid Berger; Adriana Gehmacher; Daniel Reimer; Rafal Watrowski; Dan Cacsire Castillo-Tong; Eva Schuster; Lukas Hefler; Kurt Heim; Elisabeth Mueller-Holzner; Christian Marth; Ute M Moll; Alain G Zeimet; Robert Zeillinger
Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8372-83.
2005: Ute M Moll; Sonja Wolff; Daniel Speidel; Wolfgang Deppert
Transcription-independent pro-apoptotic functions of p53.
Current opinion in cell biology 2005;17(6):631-6.
2005: Alice Nemajerova; Sonja Wolff; Oleksi Petrenko; Ute M Moll
Viral and cellular oncogenes induce rapid mitochondrial translocation of p53 in primary epithelial and endothelial cells early in apoptosis.
FEBS letters 2005;579(27):6079-83.
2005: Flaminia Talos; Oleksi Petrenko; Patricio Mena; Ute M Moll
Mitochondrially targeted p53 has tumor suppressor activities in vivo.
Cancer research 2005;65(21):9971-81.
2005: Flaminia Talos; Patricio Mena; Gunter Fingerle-Rowson; Ute M Moll; Oleksi Petrenko
MIF loss impairs Myc-induced lymphomagenesis.
Cell death and differentiation 2005;12(10):1319-28.
2005: susan erster; Ute M Moll
Stress-induced p53 runs a transcription-independent death program.
Biochemical and biophysical research communications 2005;331(3):843-50.
2005: Alice Nemajerova; susan erster; Ute M Moll
The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria.
Cell death and differentiation 2005;12(2):197-200.
2005: Oleksi Petrenko; Ute M Moll
Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway.
Molecular cell 2005;17(2):225-36.
2004: susan erster; Ute M Moll
Stress-induced p53 runs a direct mitochondrial death program: its role in physiologic and pathophysiologic stress responses in vivo.
Cell cycle (Georgetown, Tex.) 2004;3(12):1492-5.
2004: Mary Ellen Perry; Chi Dang; David M Hockenbery; Ute M Moll
Highlights of the National Cancer Institute Workshop on mitochondrial function and cancer.
Cancer research 2004;64(20):7640-4.
2004: susan erster; Motohiro Mihara; Roger H Kim; Oleksi Petrenko; Ute M Moll
In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation.
Molecular and cellular biology 2004;24(15):6728-41.
2004: Ute M Moll; Neda Slade
p63 and p73: roles in development and tumor formation.
Molecular cancer research : MCR 2004;2(7):371-86.
2004: Nicole Concin; Kirsten Becker; Neda Slade; susan erster; Elisabeth Mueller-Holzner; Hanno Ulmer; Guenter Daxenbichler; Alain G Zeimet; Robert Zeillinger; Christian Marth; Ute M Moll
Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
Cancer research 2004;64(7):2449-60.
2004: Neda Slade; Alexander Zaika; susan erster; Ute M Moll
DeltaNp73 stabilises TAp73 proteins but compromises their function due to inhibitory hetero-oligomer formation.
Cell death and differentiation 2004;11(3):357-60.
2004: Petr Pancoska; Zdenek Moravek; Ute M Moll
Rational design of DNA sequences for nanotechnology, microarrays and molecular computers using Eulerian graphs.
Nucleic acids research 2004;32(15):4630-45.
2004: Petr Pancoska; Zdenek Moravek; Ute M Moll
Efficient RNA interference depends on global context of the target sequence: quantitative analysis of silencing efficiency using Eulerian graph representation of siRNA.
Nucleic acids research 2004;32(4):1469-79.
2003: Ute M Moll; Oleksi Petrenko
The MDM2-p53 interaction.
Molecular cancer research : MCR 2003;1(14):1001-8.
2003: Ute M Moll
The Role of p63 and p73 in tumor formation and progression: coming of age toward clinical usefulness. Commentary re: F. Koga et al., Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin. Cancer Res., 9: 5501-5507, 2003, and P. Puig et al., p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder Cancer. Clin. Cancer Res., 9: 5642-5651, 2003.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(15):5437-41.
2003: Troy W Joseph; Alexander Zaika; Ute M Moll
Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(12):1622-30.
2003: Gunter Fingerle-Rowson; Oleksi Petrenko; Christine N Metz; Thomas G Forsthuber; R Mitchell; R Huss; Ute M Moll; Werner Muller; Richard Bucala
The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(16):9354-9.
2003: Oleksi Petrenko; Alexander Zaika; Ute M Moll
deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
Molecular and cellular biology 2003;23(16):5540-55.
2003: Motohiro Mihara; susan erster; Alexander Zaika; Oleksi Petrenko; Thomas Chittenden; Petr Pancoska; Ute M Moll
p53 has a direct apoptogenic role at the mitochondria.
Molecular cell 2003;11(3):577-90.
2003: Neda Slade; Ute M Moll
Mutational analysis of p53 in human tumors: immunocytochemistry.
Methods in molecular biology (Clifton, N.J.) 2003;234():231-43.
2003: susan erster; Neda Slade; Ute M Moll
Mutational analysis of p53 in human tumors: direct DNA sequencing and SSCP.
Methods in molecular biology (Clifton, N.J.) 2003;234():219-30.
2003: Troy W Joseph; Ute M Moll
Analysis of nuclear and cytoplasmic degradation of p53 in cells after stress.
Methods in molecular biology (Clifton, N.J.) 2003;234():211-7.
2003: Motohiro Mihara; Ute M Moll
Detection of mitochondrial localization of p53.
Methods in molecular biology (Clifton, N.J.) 2003;234():203-9.
2002: Alexander Zaika; Neda Slade; susan erster; Christine Sansome; Troy W Joseph; Michael L Pearl; Eva Chalas; Ute M Moll
DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
The Journal of experimental medicine 2002;196(6):765-80.
2002: Troy R Shirangi; Alexander Zaika; Ute M Moll
Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(3):420-2.
2002: Sétha Douc-Rasy; Michel Barrois; Maria Echeynne; Mourad Kaghad; Etienne Blanc; Gilda Raguenez; David Goldschneider; Marie-José Terrier-Lacombe; Olivier Hartmann; Ute M Moll; Daniel Caput; Jean Bénard
DeltaN-p73alpha accumulates in human neuroblastic tumors.
The American journal of pathology 2002;160(2):631-9.
2001: Ute M Moll; susan erster; Alexander Zaika
p53, p63 and p73--solos, alliances and feuds among family members.
Biochimica et biophysica acta 2001;1552(2):47-59.
2001: Alexander Zaika; M Irwin; Christine Sansome; Ute M Moll
Oncogenes induce and activate endogenous p73 protein.
The Journal of biological chemistry 2001;276(14):11310-6.
2001: Ute M Moll; Alexander Zaika
Nuclear and mitochondrial apoptotic pathways of p53.
FEBS letters 2001;493(2-3):65-9.
2001: Christine Sansome; Alexander Zaika; Natasha D Marchenko; Ute M Moll
Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells.
FEBS letters 2001;488(3):110-5.
2001: R Lau; R Grimson; Christine Sansome; Carmen Tornos; Ute M Moll
Low levels of cell cycle inhibitor p27kip1 combined with high levels of Ki-67 predict shortened disease-free survival in T1 and T2 invasive breast carcinomas.
International journal of oncology 2001;18(1):17-23.
2000: Natasha D Marchenko; Alexander Zaika; Ute M Moll
Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling.
The Journal of biological chemistry 2000;275(21):16202-12.
2000: Sergey Kovalev; A Mateen; Alexander Zaika; B J O'Hea; Ute M Moll
Lack of defective expression of the ATM gene in sporadic breast cancer tissues and cell lines.
International journal of oncology 2000;16(4):825-31.
2000: Tarik Tihan; R Davis; Eric Elowitz; D DiCostanzo; Ute M Moll
Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas.
Archives of pathology & laboratory medicine 2000;124(1):108-13.
1999: Alexander Zaika; Natasha D Marchenko; Ute M Moll
Cytoplasmically "sequestered" wild type p53 protein is resistant to Mdm2-mediated degradation.
The Journal of biological chemistry 1999;274(39):27474-80.
1999: Alexander Zaika; Sergey Kovalev; Natasha D Marchenko; Ute M Moll
Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
Cancer research 1999;59(13):3257-63.
1999: Ute M Moll; R Lau; M A Sypes; M M Gupta; C W Anderson
DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues.
Oncogene 1999;18(20):3114-26.
1999: Jayne M Stommel; Natasha D Marchenko; GS Jimenez; Ute M Moll; TJ Hope; Geoffrey M Wahl
A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.
The EMBO journal 1999;18(6):1660-72.
1998: Sergey Kovalev; Natasha D Marchenko; S Swendeman; Michael P LaQuaglia; Ute M Moll
Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1998;9(11):897-903.
1998: Sergey Kovalev; Natasha D Marchenko; B G Gugliotta; Eva Chalas; J Chumas; Ute M Moll
Loss of p53 function in uterine papillary serous carcinoma.
Human pathology 1998;29(6):613-9.
1998: Ute M Moll; L M Schramm
p53--an acrobat in tumorigenesis.
Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists 1998;9(1):23-37.
1997: Natasha D Marchenko; Ute M Moll
Nuclear overexpression of p53 protein does not correlate with gene mutation in primary peritoneal carcinoma.
Human pathology 1997;28(9):1002-6.
1997: Ute M Moll
Functional histology of the neuroendocrine thymus.
Microscopy research and technique 1997;38(3):300-10.
1997: Ute M Moll; F Valea; J Chumas
Role of p53 alteration in primary peritoneal carcinoma.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1997;16(2):156-62.
1997: Adam J Singer; P M Migdal; J P Oken; S N Chale; Ute M Moll
Clostridium perfringens septicemia with massive hemolysis in a patient with Hodgkin's lymphoma.
The American journal of emergency medicine 1997;15(2):152-4.
1997: Ute M Moll; J Chumas
Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer.
Pathology, research and practice 1997;193(3):187-96.
1996: A G Ostermeyer; E Runko; B Winkfield; B Ahn; Ute M Moll
Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(26):15190-4.
1996: Ute M Moll; Eva Chalas; M Auguste; D Meaney; J Chumas
Uterine papillary serous carcinoma evolves via a p53-driven pathway.
Human pathology 1996;27(12):1295-300.
1996: M E Herrmann; P A Lalley; Linea L Rydstedt; E Meese; C H Lang; Naji N Abumrad; Ute M Moll; Gary B Talpos
Double minutes in the papillary thyroid cancer cell line PTC-1113A.
Cancer genetics and cytogenetics 1996;90(1):70-4.
1996: Ute M Moll; A G Ostermeyer; R Haladay; B Winkfield; M Frazier; G Zambetti
Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage.
Molecular and cellular biology 1996;16(3):1126-37.
1995: Ute M Moll; A G Ostermeyer; J C Ahomadegbe; Marie-Christine Mathieu; G Riou
p53 mediated tumor cell response to chemotherapeutic DNA damage: a preliminary study in matched pairs of breast cancer biopsies.
Human pathology 1995;26(12):1293-301.
1995: Stanley Zucker; R M Lysik; B I DiMassimo; H M Zarrabi; Ute M Moll; R Grimson; S P Tickle; A J Docherty
Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer.
Cancer 1995;76(4):700-8.
1995: Ute M Moll; Michael P LaQuaglia; J Bénard; G Riou
Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(10):4407-11.
1994: Stanley Zucker; R M Lysik; H M Zarrabi; Ute M Moll; S P Tickle; W Stetler-Stevenson; T S Baker; A J Docherty
Plasma assay of matrix metalloproteinases (MMPs) and MMP-inhibitor complexes in cancer. Potential use in predicting metastasis and monitoring treatment.
Annals of the New York Academy of Sciences 1994;732():248-62.
1993: G Riou; Monique G Lê; Jean-Paul Travagli; Arnold J Levine; Ute M Moll
Poor prognosis of p53 gene mutation and nuclear overexpression of p53 protein in inflammatory breast carcinoma.
Journal of the National Cancer Institute 1993;85(21):1765-7.
1993: N Ramos-DeSimone; Ute M Moll; James P Quigley; D L French
Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody.
Hybridoma 1993;12(4):349-63.
1993: Stanley Zucker; R M Lysik; M H Zarrabi; Ute M Moll
M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.
Cancer research 1993;53(1):140-6.
1992: Ute M Moll; G Riou; Arnold J Levine
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(15):7262-6.
1992: Stanley Zucker; Ute M Moll; R M Lysik; E I DiMassimo; J W Schwedes; L A Liotta
Extraction of type IV collagenase/gelatinase from plasma membranes of human pancreatic cancer cells.
Matrix (Stuttgart, Germany). Supplement 1992;1():411.
1990: Ute M Moll; B Lane; S Zucker; K Suzuki; H Nagase
Localization of collagenase at the basal plasma membrane of a human pancreatic carcinoma cell line.
Cancer research 1990;50(21):6995-7002.
1990: Ute M Moll; J C Chumas; W J Mann; B Patsner
Primary signet ring cell carcinoma of the uterine cervix.
New York state journal of medicine 1990;90(11):559-60.
1990: Ute M Moll; G L Youngleib; K B Rosinski; James P Quigley
Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.
Cancer research 1990;50(19):6162-70.
1990: Stanley Zucker; Ute M Moll; R M Lysik; E I DiMassimo; W G Stetler-Stevenson; L A Liotta; J W Schwedes
Extraction of type-IV collagenase/gelatinase from plasma membranes of human cancer cells.
International journal of cancer. Journal international du cancer 1990;45(6):1137-42.
1990: Ute M Moll; J C Chumas; Eva Chalas; W J Mann
Ovarian carcinoma arising in atypical endometriosis.
Obstetrics and gynecology 1990;75(3 Pt 2):537-9.
1990: Ute M Moll; B L Lane
Proteolytic activity of first trimester human placenta: localization of interstitial collagenase in villous and extravillous trophoblast.
Histochemistry 1990;94(5):555-60.
1989: A Heimann; Ute M Moll
Spinal metastasis of a thyroglobulin-rich Hürthle cell carcinoma detected by fine needle aspiration. Light and electron microscopic study of an unusual case.
Acta cytologica 1989;33(5):639-44.
1988: Ute M Moll; B L Lane; F Robert; V Geenen; J J Legros
The neuroendocrine thymus. Abundant occurrence of oxytocin-, vasopressin-, and neurophysin-like peptides in epithelial cells.
Histochemistry 1988;89(4):385-90.
1987: Ute M Moll; C F Ilardi; R Zuna; M E Phillips
A biologically active parathyroid hormone-like substance secreted by an adenosquamous carcinoma of the transverse colon.
Human pathology 1987;18(12):1287-90.
1986: Ute M Moll; C Thun; E F Pfeiffer
Colloidal gold-labeled insulin complex. Characterization and binding to adipocytes.
Histochemistry 1986;86(1):83-8.
1983: R Martin; Ute M Moll; K H Voigt
An attempt to characterize by immunocytochemical methods the enkephalin-like material in oxytocin endings of the rat neurohypophysis.
Life sciences 1983;33 Suppl 1():69-72.